NHO Revive marks Breast Cancer Awareness Month with screening push

NHO Revive is using Breast Cancer Awareness Month to urge people in Nebraska and beyond to watch for warning signs, stay current on screenings, and consider clinical research as a path to better breast cancer care. The Lincoln-based research group says early detection and trial participation have helped drive major gains in survival and treatment.

Why it matters: - Breast cancer affects about 1 in 8 women in the United States over a lifetime, according to the American Cancer Society. - When breast cancer is found before it spreads beyond the breast, the five-year survival rate is over 99%. - Earlier detection can expand treatment options and improve outcomes.

What happened: - NHO Revive, a clinical research organization based in Lincoln, is marking Breast Cancer Awareness Month with a call to action. - The organization is urging people to know their bodies, keep up with screenings and understand how clinical research is advancing breast cancer care. - NHO Revive is also directing people to learn more about its research and current breast cancer studies.

The details: - NHO Revive says people should watch for a new lump or thickening in the breast or underarm. - The organization also lists changes in breast size, shape or appearance as warning signs. - Skin dimpling, redness or irritation should be checked by a healthcare provider. - Nipple changes or unusual discharge are also signs to discuss with a clinician. - Persistent pain in one area deserves medical attention. - Most breast changes are not cancer, but every change should be checked. - Men can develop breast cancer too, and the same guidance applies. - Screening timing depends on age, family history and personal risk. - A primary care provider can help decide when to start mammograms and how often to get them. - People with a family history of breast or ovarian cancer should ask about earlier or additional screening. - NHO Revive says fear and stigma still keep too many people from being checked. - Encouraging a friend or family member to book an appointment, or offering to go with them, can help. - Breast cancer deaths among U.S. women fell 44% between 1989 and 2022, a drop linked to earlier detection and better treatments. - NHO Revive says those treatments exist because people participated in clinical trials. - The organization conducts studies of investigational therapies for early-stage and metastatic breast cancer. - Eligible patients in Nebraska can access emerging options close to home, near family and support networks. - Every study is carefully reviewed and closely monitored, and participation is voluntary.

Between the lines: - The message blends prevention with research recruitment. - NHO Revive is positioning clinical trials as part of routine cancer progress, not as a last resort. - Local access matters because geography can be a barrier for patients who need ongoing treatment or frequent study visits.

What's next: - People with symptoms or risk concerns are being encouraged to talk with a healthcare provider. - Patients considering new treatment options can discuss clinical trials with their care team. - NHO Revive says its breast cancer studies remain available for eligible patients across Nebraska.

The bottom line: - Breast cancer awareness is not just about recognition. It is about earlier screening, faster follow-up and keeping clinical research moving forward.